MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Biota Pharmaceuticals Company Profile (NASDAQ:BOTA)

Consensus Ratings for Biota Pharmaceuticals (NASDAQ:BOTA) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.00 (322.54% upside)

Analysts' Ratings History for Biota Pharmaceuticals (NASDAQ:BOTA)
Show:
DateFirmActionRatingPrice TargetActions
2/8/2016FBR & Co.Reiterated RatingOutperform$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2016FBR & Co.Initiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016FBR & Co.Reiterated RatingOutperform$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016HSBCInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/28/2015FBR & Co.Initiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2015FBR & Co.Initiated CoverageOutperform$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2014GuggenheimDowngradeBuy -> Neutral$5.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/11/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha